Literature DB >> 11009459

Time course of vasodilatory responses in skeletal muscle arterioles: role in hyperemia at onset of exercise.

S A Wunsch1, J Muller-Delp, M D Delp.   

Abstract

At the onset of dynamic exercise, muscle blood flow increases within 1-2 s. It has been postulated that local vasodilatory agents produced by the vascular endothelium or the muscle itself contribute to this response. We hypothesized that only vasodilators that act directly on the vascular smooth muscle could produce vasodilation of skeletal muscle arterioles in <2 s. To test this hypothesis, we determined the time course of the vasodilatory response of isolated skeletal muscle arterioles to direct application of potassium chloride, adenosine, acetylcholine, and sodium nitroprusside. Soleus and gastrocnemius muscles were dissected from the hindlimbs of male Sprague-Dawley rats. First-order arterioles (100-200 microm) were isolated, cannulated on micropipettes, and pressurized to 60 cmH(2)O in an organ bath. Vasodilatory agents were added directly to the bath, and diameter responses of the arterioles were recorded in real time on a videotape recorder. Frame-by-frame analysis of the diameter responses indicated that none of the vasodilator agents tested produced significant diameter increases in <4 s in either soleus or gastrocnemius muscle arterioles. These results indicate that, although these local vasodilators produce significant vasodilation of skeletal muscle resistance arterioles, these responses are not rapid enough (within 1-2 s) to contribute to the initiation of the exercise hyperemic response at the onset of dynamic exercise.

Entities:  

Keywords:  NASA Discipline Musculoskeletal; Non-NASA Center

Mesh:

Substances:

Year:  2000        PMID: 11009459     DOI: 10.1152/ajpheart.2000.279.4.H1715

Source DB:  PubMed          Journal:  Am J Physiol Heart Circ Physiol        ISSN: 0363-6135            Impact factor:   4.733


  33 in total

1.  Cardiovascular response to dynamic aerobic exercise: a mathematical model.

Authors:  E Magosso; M Ursino
Journal:  Med Biol Eng Comput       Date:  2002-11       Impact factor: 2.602

2.  Heterogeneous ageing of skeletal muscle microvascular function.

Authors:  Judy M Muller-Delp
Journal:  J Physiol       Date:  2015-12-20       Impact factor: 5.182

3.  Onset exercise hyperaemia in humans: partitioning the contributors.

Authors:  D Walter Wray; Anthony J Donato; Abhimanyu Uberoi; Joseph P Merlone; Russell S Richardson
Journal:  J Physiol       Date:  2005-04-28       Impact factor: 5.182

Review 4.  Physiological Impact and Clinical Relevance of Passive Exercise/Movement.

Authors:  Joel D Trinity; Russell S Richardson
Journal:  Sports Med       Date:  2019-09       Impact factor: 11.136

Review 5.  Skeletal muscle vasodilatation at the onset of exercise.

Authors:  Philip S Clifford
Journal:  J Physiol       Date:  2007-07-05       Impact factor: 5.182

6.  Potassium, contracting myocytes and rapid vasodilatation: peaking more than just our interest?

Authors:  Brett S Kirby; Rick E Carlson
Journal:  J Physiol       Date:  2007-11-15       Impact factor: 5.182

7.  Pattern of deoxy[Hb+Mb] during ramp cycle exercise: influence of aerobic fitness status.

Authors:  Jan Boone; Katrien Koppo; Thomas J Barstow; Jacques Bouckaert
Journal:  Eur J Appl Physiol       Date:  2009-01-08       Impact factor: 3.078

8.  Recovery of blood flow regulation in microvascular resistance networks during regeneration of mouse gluteus maximus muscle.

Authors:  Charmain A Fernando; Aaron M Pangan; Ddw Cornelison; Steven S Segal
Journal:  J Physiol       Date:  2019-02-03       Impact factor: 5.182

9.  Influence of priming exercise on muscle deoxy[Hb + Mb] during ramp cycle exercise.

Authors:  Jan Boone; Jacques Bouckaert; Thomas J Barstow; Jan Bourgois
Journal:  Eur J Appl Physiol       Date:  2011-07-16       Impact factor: 3.078

10.  Vasodilatation is obligatory for contraction-induced hyperaemia in canine skeletal muscle.

Authors:  Jason J Hamann; John B Buckwalter; Philip S Clifford
Journal:  J Physiol       Date:  2004-04-08       Impact factor: 5.182

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.